Sébastien Peltier

CEO at Valbiotis

After completing a thesis on nutrition in the field of cardiovascular and metabolic diseases at the Laboratory of Applied and Fundamental Bioenergetics (U1055 INSERM) at Joseph Fourier University (Grenoble, France) under the supervision of Professor Xavier Leverve, Sébastien worked at a spin-off of the Free University of Brussels in Belgium on a drug candidate in the area of enteral and parenteral nutrition. In 2007, he joined the Lescuyer Laboratory, where he was rapidly entrusted with management of the Research & Development Department. In this position, he notably oversaw the entire application process for one of the only health claims ever to obtain a positive response from the EFSA for reducing a risk factor for cardiovascular diseases. Sébastien chaired the Biopôle Santé – Réseau Expert, Territoire d’Innovation, Service de Valorisation en Santé (regional expert network for innovation and optimization in the health sector) for the Poitou-Charentes region and later for Nouvelle-Aquitaine for over five years until March 2017. He was also granted the French higher degree authorizing the supervision of research (HDR – Habilitation à Diriger des Recherches) from Blaise Pascal University (which later became the University of Clermont Auvergne, Clermont-Ferrand), allowing him to officially supervise PhD students. Sébastien is an active member of the French Nutrition Society and the American Diabetes Association. He is also a member of the Strategic Committee of La Rochelle Technopole and President of the La Rochelle University Foundation. Sébastien has written over 35 international scientific articles and papers, and has developed more than five patent families.

Links

Timeline

  • CEO

    December, 2014 - present

View in org chart